カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のHIV治療薬市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Drugs for HIV Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19275）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19275
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：96
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のHIV治療薬市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

HIV治療薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のHIV治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

HIV治療薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・非ヌクレオシド系逆転写酵素阻害剤（NNRTI）、インテグラーゼ阻害剤、HIV併用療法、その他

用途別セグメントは次のように区分されます。
・病院調剤薬局、総合調剤薬局、オンライン調剤薬局、その他

世界のHIV治療薬市場の主要な市場プレーヤーは以下のとおりです。
・ViiV Healthcare、Gilead Sciences, Inc、Merck Sharp & Dohme Corp、Bristol-Myers Squibb Company、Janssen Pharmaceuticals, Inc.、Theratechnologies Inc.、Mylan Pharmaceuticals Inc.、Genentech, Inc.、AbbVie Inc.

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、HIV治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なHIV治療薬メーカーの企業概要、2019年～2022年までのHIV治療薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なHIV治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別HIV治療薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのHIV治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのHIV治療薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびHIV治療薬の産業チェーンを掲載しています。
・第13、14、15章では、HIV治療薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- HIV治療薬の概要
- 種類別分析（2017年vs2021年vs2028年）：非ヌクレオシド系逆転写酵素阻害剤（NNRTI）、インテグラーゼ阻害剤、HIV併用療法、その他
- 用途別分析（2017年vs2021年vs2028年）：病院調剤薬局、総合調剤薬局、オンライン調剤薬局、その他
- 世界のHIV治療薬市場規模・予測
- 世界のHIV治療薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- ViiV Healthcare、Gilead Sciences, Inc、Merck Sharp & Dohme Corp、Bristol-Myers Squibb Company、Janssen Pharmaceuticals, Inc.、Theratechnologies Inc.、Mylan Pharmaceuticals Inc.、Genentech, Inc.、AbbVie Inc.
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：非ヌクレオシド系逆転写酵素阻害剤（NNRTI）、インテグラーゼ阻害剤、HIV併用療法、その他
・用途別分析2017年-2028年：病院調剤薬局、総合調剤薬局、オンライン調剤薬局、その他
・HIV治療薬の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・HIV治療薬のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・HIV治療薬のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・HIV治療薬の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・HIV治療薬の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Drugs for HIV market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Drugs for HIV market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacies accounting for % of the Drugs for HIV global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Drugs for HIV include ViiV Healthcare, Gilead Sciences, Inc, Merck Sharp & Dohme Corp, Bristol-Myers Squibb Company, and Janssen Pharmaceuticals, Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Drugs for HIV market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Integrase Inhibitors
Combination HIV Medicines
Others
Market segment by Application can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
The key market players for global Drugs for HIV market are listed below:
ViiV Healthcare
Gilead Sciences, Inc
Merck Sharp & Dohme Corp
Bristol-Myers Squibb Company
Janssen Pharmaceuticals, Inc.
Theratechnologies Inc.
Mylan Pharmaceuticals Inc.
Genentech, Inc.
AbbVie Inc.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drugs for HIV product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Drugs for HIV, with price, sales, revenue and global market share of Drugs for HIV from 2019 to 2022.
Chapter 3, the Drugs for HIV competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drugs for HIV breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Drugs for HIV market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drugs for HIV.
Chapter 13, 14, and 15, to describe Drugs for HIV sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Drugs for HIV Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Drugs for HIV Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
1.2.3 Integrase Inhibitors
1.2.4 Combination HIV Medicines
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Drugs for HIV Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Global Drugs for HIV Market Size & Forecast
1.4.1 Global Drugs for HIV Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Drugs for HIV Sales in Volume (2017-2028)
1.4.3 Global Drugs for HIV Price (2017-2028)
1.5 Global Drugs for HIV Production Capacity Analysis
1.5.1 Global Drugs for HIV Total Production Capacity (2017-2028)
1.5.2 Global Drugs for HIV Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Drugs for HIV Market Drivers
1.6.2 Drugs for HIV Market Restraints
1.6.3 Drugs for HIV Trends Analysis
2 Manufacturers Profiles
2.1 ViiV Healthcare
2.1.1 ViiV Healthcare Details
2.1.2 ViiV Healthcare Major Business
2.1.3 ViiV Healthcare Drugs for HIV Product and Services
2.1.4 ViiV Healthcare Drugs for HIV Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Gilead Sciences, Inc
2.2.1 Gilead Sciences, Inc Details
2.2.2 Gilead Sciences, Inc Major Business
2.2.3 Gilead Sciences, Inc Drugs for HIV Product and Services
2.2.4 Gilead Sciences, Inc Drugs for HIV Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Merck Sharp & Dohme Corp
2.3.1 Merck Sharp & Dohme Corp Details
2.3.2 Merck Sharp & Dohme Corp Major Business
2.3.3 Merck Sharp & Dohme Corp Drugs for HIV Product and Services
2.3.4 Merck Sharp & Dohme Corp Drugs for HIV Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Bristol-Myers Squibb Company
2.4.1 Bristol-Myers Squibb Company Details
2.4.2 Bristol-Myers Squibb Company Major Business
2.4.3 Bristol-Myers Squibb Company Drugs for HIV Product and Services
2.4.4 Bristol-Myers Squibb Company Drugs for HIV Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Janssen Pharmaceuticals, Inc.
2.5.1 Janssen Pharmaceuticals, Inc. Details
2.5.2 Janssen Pharmaceuticals, Inc. Major Business
2.5.3 Janssen Pharmaceuticals, Inc. Drugs for HIV Product and Services
2.5.4 Janssen Pharmaceuticals, Inc. Drugs for HIV Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Theratechnologies Inc.
2.6.1 Theratechnologies Inc. Details
2.6.2 Theratechnologies Inc. Major Business
2.6.3 Theratechnologies Inc. Drugs for HIV Product and Services
2.6.4 Theratechnologies Inc. Drugs for HIV Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Mylan Pharmaceuticals Inc.
2.7.1 Mylan Pharmaceuticals Inc. Details
2.7.2 Mylan Pharmaceuticals Inc. Major Business
2.7.3 Mylan Pharmaceuticals Inc. Drugs for HIV Product and Services
2.7.4 Mylan Pharmaceuticals Inc. Drugs for HIV Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Genentech, Inc.
2.8.1 Genentech, Inc. Details
2.8.2 Genentech, Inc. Major Business
2.8.3 Genentech, Inc. Drugs for HIV Product and Services
2.8.4 Genentech, Inc. Drugs for HIV Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 AbbVie Inc.
2.9.1 AbbVie Inc. Details
2.9.2 AbbVie Inc. Major Business
2.9.3 AbbVie Inc. Drugs for HIV Product and Services
2.9.4 AbbVie Inc. Drugs for HIV Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Drugs for HIV Breakdown Data by Manufacturer
3.1 Global Drugs for HIV Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Drugs for HIV Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Drugs for HIV
3.4 Market Concentration Rate
3.4.1 Top 3 Drugs for HIV Manufacturer Market Share in 2021
3.4.2 Top 6 Drugs for HIV Manufacturer Market Share in 2021
3.5 Global Drugs for HIV Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Drugs for HIV Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Drugs for HIV Market Size by Region
4.1.1 Global Drugs for HIV Sales in Volume by Region (2017-2028)
4.1.2 Global Drugs for HIV Revenue by Region (2017-2028)
4.2 North America Drugs for HIV Revenue (2017-2028)
4.3 Europe Drugs for HIV Revenue (2017-2028)
4.4 Asia-Pacific Drugs for HIV Revenue (2017-2028)
4.5 South America Drugs for HIV Revenue (2017-2028)
4.6 Middle East and Africa Drugs for HIV Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Drugs for HIV Sales in Volume by Type (2017-2028)
5.2 Global Drugs for HIV Revenue by Type (2017-2028)
5.3 Global Drugs for HIV Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Drugs for HIV Sales in Volume by Application (2017-2028)
6.2 Global Drugs for HIV Revenue by Application (2017-2028)
6.3 Global Drugs for HIV Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Drugs for HIV Sales by Type (2017-2028)
7.2 North America Drugs for HIV Sales by Application (2017-2028)
7.3 North America Drugs for HIV Market Size by Country
7.3.1 North America Drugs for HIV Sales in Volume by Country (2017-2028)
7.3.2 North America Drugs for HIV Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Drugs for HIV Sales by Type (2017-2028)
8.2 Europe Drugs for HIV Sales by Application (2017-2028)
8.3 Europe Drugs for HIV Market Size by Country
8.3.1 Europe Drugs for HIV Sales in Volume by Country (2017-2028)
8.3.2 Europe Drugs for HIV Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Drugs for HIV Sales by Type (2017-2028)
9.2 Asia-Pacific Drugs for HIV Sales by Application (2017-2028)
9.3 Asia-Pacific Drugs for HIV Market Size by Region
9.3.1 Asia-Pacific Drugs for HIV Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Drugs for HIV Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Drugs for HIV Sales by Type (2017-2028)
10.2 South America Drugs for HIV Sales by Application (2017-2028)
10.3 South America Drugs for HIV Market Size by Country
10.3.1 South America Drugs for HIV Sales in Volume by Country (2017-2028)
10.3.2 South America Drugs for HIV Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Drugs for HIV Sales by Type (2017-2028)
11.2 Middle East & Africa Drugs for HIV Sales by Application (2017-2028)
11.3 Middle East & Africa Drugs for HIV Market Size by Country
11.3.1 Middle East & Africa Drugs for HIV Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Drugs for HIV Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Drugs for HIV and Key Manufacturers
12.2 Manufacturing Costs Percentage of Drugs for HIV
12.3 Drugs for HIV Production Process
12.4 Drugs for HIV Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Drugs for HIV Typical Distributors
13.3 Drugs for HIV Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Drugs for HIV Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Drugs for HIV Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. ViiV Healthcare Basic Information, Manufacturing Base and Competitors
Table 4. ViiV Healthcare Major Business
Table 5. ViiV Healthcare Drugs for HIV Product and Services
Table 6. ViiV Healthcare Drugs for HIV Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Gilead Sciences, Inc Basic Information, Manufacturing Base and Competitors
Table 8. Gilead Sciences, Inc Major Business
Table 9. Gilead Sciences, Inc Drugs for HIV Product and Services
Table 10. Gilead Sciences, Inc Drugs for HIV Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Merck Sharp & Dohme Corp Basic Information, Manufacturing Base and Competitors
Table 12. Merck Sharp & Dohme Corp Major Business
Table 13. Merck Sharp & Dohme Corp Drugs for HIV Product and Services
Table 14. Merck Sharp & Dohme Corp Drugs for HIV Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 16. Bristol-Myers Squibb Company Major Business
Table 17. Bristol-Myers Squibb Company Drugs for HIV Product and Services
Table 18. Bristol-Myers Squibb Company Drugs for HIV Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Janssen Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 20. Janssen Pharmaceuticals, Inc. Major Business
Table 21. Janssen Pharmaceuticals, Inc. Drugs for HIV Product and Services
Table 22. Janssen Pharmaceuticals, Inc. Drugs for HIV Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Theratechnologies Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Theratechnologies Inc. Major Business
Table 25. Theratechnologies Inc. Drugs for HIV Product and Services
Table 26. Theratechnologies Inc. Drugs for HIV Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Mylan Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 28. Mylan Pharmaceuticals Inc. Major Business
Table 29. Mylan Pharmaceuticals Inc. Drugs for HIV Product and Services
Table 30. Mylan Pharmaceuticals Inc. Drugs for HIV Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Genentech, Inc. Basic Information, Manufacturing Base and Competitors
Table 32. Genentech, Inc. Major Business
Table 33. Genentech, Inc. Drugs for HIV Product and Services
Table 34. Genentech, Inc. Drugs for HIV Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. AbbVie Inc. Basic Information, Manufacturing Base and Competitors
Table 36. AbbVie Inc. Major Business
Table 37. AbbVie Inc. Drugs for HIV Product and Services
Table 38. AbbVie Inc. Drugs for HIV Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Drugs for HIV Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Drugs for HIV Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Drugs for HIV, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Drugs for HIV Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Drugs for HIV Production Site of Key Manufacturer
Table 44. Drugs for HIV New Entrant and Capacity Expansion Plans
Table 45. Drugs for HIV Mergers & Acquisitions in the Past Five Years
Table 46. Global Drugs for HIV Sales by Region (2017-2022) & (K Units)
Table 47. Global Drugs for HIV Sales by Region (2023-2028) & (K Units)
Table 48. Global Drugs for HIV Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Drugs for HIV Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Drugs for HIV Sales by Type (2017-2022) & (K Units)
Table 51. Global Drugs for HIV Sales by Type (2023-2028) & (K Units)
Table 52. Global Drugs for HIV Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Drugs for HIV Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Drugs for HIV Price by Type (2017-2022) & (US$/Unit)
Table 55. Global Drugs for HIV Price by Type (2023-2028) & (US$/Unit)
Table 56. Global Drugs for HIV Sales by Application (2017-2022) & (K Units)
Table 57. Global Drugs for HIV Sales by Application (2023-2028) & (K Units)
Table 58. Global Drugs for HIV Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Drugs for HIV Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Drugs for HIV Price by Application (2017-2022) & (US$/Unit)
Table 61. Global Drugs for HIV Price by Application (2023-2028) & (US$/Unit)
Table 62. North America Drugs for HIV Sales by Country (2017-2022) & (K Units)
Table 63. North America Drugs for HIV Sales by Country (2023-2028) & (K Units)
Table 64. North America Drugs for HIV Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Drugs for HIV Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Drugs for HIV Sales by Type (2017-2022) & (K Units)
Table 67. North America Drugs for HIV Sales by Type (2023-2028) & (K Units)
Table 68. North America Drugs for HIV Sales by Application (2017-2022) & (K Units)
Table 69. North America Drugs for HIV Sales by Application (2023-2028) & (K Units)
Table 70. Europe Drugs for HIV Sales by Country (2017-2022) & (K Units)
Table 71. Europe Drugs for HIV Sales by Country (2023-2028) & (K Units)
Table 72. Europe Drugs for HIV Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Drugs for HIV Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Drugs for HIV Sales by Type (2017-2022) & (K Units)
Table 75. Europe Drugs for HIV Sales by Type (2023-2028) & (K Units)
Table 76. Europe Drugs for HIV Sales by Application (2017-2022) & (K Units)
Table 77. Europe Drugs for HIV Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Drugs for HIV Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Drugs for HIV Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Drugs for HIV Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Drugs for HIV Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Drugs for HIV Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Drugs for HIV Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Drugs for HIV Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Drugs for HIV Sales by Application (2023-2028) & (K Units)
Table 86. South America Drugs for HIV Sales by Country (2017-2022) & (K Units)
Table 87. South America Drugs for HIV Sales by Country (2023-2028) & (K Units)
Table 88. South America Drugs for HIV Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Drugs for HIV Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Drugs for HIV Sales by Type (2017-2022) & (K Units)
Table 91. South America Drugs for HIV Sales by Type (2023-2028) & (K Units)
Table 92. South America Drugs for HIV Sales by Application (2017-2022) & (K Units)
Table 93. South America Drugs for HIV Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Drugs for HIV Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Drugs for HIV Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Drugs for HIV Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Drugs for HIV Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Drugs for HIV Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Drugs for HIV Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Drugs for HIV Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Drugs for HIV Sales by Application (2023-2028) & (K Units)
Table 102. Drugs for HIV Raw Material
Table 103. Key Manufacturers of Drugs for HIV Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Drugs for HIV Typical Distributors
Table 107. Drugs for HIV Typical Customers
List of Figures
Figure 1. Drugs for HIV Picture
Figure 2. Global Drugs for HIV Revenue Market Share by Type in 2021
Figure 3. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Figure 4. Integrase Inhibitors
Figure 5. Combination HIV Medicines
Figure 6. Others
Figure 7. Global Drugs for HIV Revenue Market Share by Application in 2021
Figure 8. Hospital Pharmacies
Figure 9. Retail Pharmacies
Figure 10. Online Pharmacies
Figure 11. Others
Figure 12. Global Drugs for HIV Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 13. Global Drugs for HIV Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Drugs for HIV Sales (2017-2028) & (K Units)
Figure 15. Global Drugs for HIV Price (2017-2028) & (US$/Unit)
Figure 16. Global Drugs for HIV Production Capacity (2017-2028) & (K Units)
Figure 17. Global Drugs for HIV Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Drugs for HIV Market Drivers
Figure 19. Drugs for HIV Market Restraints
Figure 20. Drugs for HIV Market Trends
Figure 21. Global Drugs for HIV Sales Market Share by Manufacturer in 2021
Figure 22. Global Drugs for HIV Revenue Market Share by Manufacturer in 2021
Figure 23. Drugs for HIV Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Drugs for HIV Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Drugs for HIV Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Drugs for HIV Sales Market Share by Region (2017-2028)
Figure 27. Global Drugs for HIV Revenue Market Share by Region (2017-2028)
Figure 28. North America Drugs for HIV Revenue (2017-2028) & (USD Million)
Figure 29. Europe Drugs for HIV Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Drugs for HIV Revenue (2017-2028) & (USD Million)
Figure 31. South America Drugs for HIV Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Drugs for HIV Revenue (2017-2028) & (USD Million)
Figure 33. Global Drugs for HIV Sales Market Share by Type (2017-2028)
Figure 34. Global Drugs for HIV Revenue Market Share by Type (2017-2028)
Figure 35. Global Drugs for HIV Price by Type (2017-2028) & (US$/Unit)
Figure 36. Global Drugs for HIV Sales Market Share by Application (2017-2028)
Figure 37. Global Drugs for HIV Revenue Market Share by Application (2017-2028)
Figure 38. Global Drugs for HIV Price by Application (2017-2028) & (US$/Unit)
Figure 39. North America Drugs for HIV Sales Market Share by Type (2017-2028)
Figure 40. North America Drugs for HIV Sales Market Share by Application (2017-2028)
Figure 41. North America Drugs for HIV Sales Market Share by Country (2017-2028)
Figure 42. North America Drugs for HIV Revenue Market Share by Country (2017-2028)
Figure 43. United States Drugs for HIV Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Drugs for HIV Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Drugs for HIV Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Drugs for HIV Sales Market Share by Type (2017-2028)
Figure 47. Europe Drugs for HIV Sales Market Share by Application (2017-2028)
Figure 48. Europe Drugs for HIV Sales Market Share by Country (2017-2028)
Figure 49. Europe Drugs for HIV Revenue Market Share by Country (2017-2028)
Figure 50. Germany Drugs for HIV Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Drugs for HIV Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Drugs for HIV Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Drugs for HIV Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Drugs for HIV Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Drugs for HIV Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Drugs for HIV Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Drugs for HIV Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Drugs for HIV Revenue Market Share by Region (2017-2028)
Figure 59. China Drugs for HIV Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Drugs for HIV Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Drugs for HIV Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Drugs for HIV Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Drugs for HIV Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Drugs for HIV Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Drugs for HIV Sales Market Share by Type (2017-2028)
Figure 66. South America Drugs for HIV Sales Market Share by Application (2017-2028)
Figure 67. South America Drugs for HIV Sales Market Share by Country (2017-2028)
Figure 68. South America Drugs for HIV Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Drugs for HIV Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Drugs for HIV Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Drugs for HIV Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Drugs for HIV Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Drugs for HIV Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Drugs for HIV Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Drugs for HIV Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Drugs for HIV Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Drugs for HIV Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Drugs for HIV Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Drugs for HIV in 2021
Figure 80. Manufacturing Process Analysis of Drugs for HIV
Figure 81. Drugs for HIV Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のオシメルチニブ医薬品市場2022年：市場規模予測（～2028年）
  • 世界のエクセナチド薬物市場2022年：市場規模予測（～2028年）
  • 世界のペガスパルガーゼ薬物市場2022年：市場規模予測（～2028年）
  • 世界のリロナセプト薬物市場2022年：市場規模予測（～2028年）
  • 世界のブリナツモマブ治療薬市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19275 )"世界のHIV治療薬市場2022年：市場規模予測（～2028年）" (英文：Global Drugs for HIV Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。